Baeten DL - Search Results

1

Soluble biomarkers of cartilage and bone metabolism in early proof of concept trials in psoriatic arthritis: effects of adalimumab versus placebo.

van Kuijk AW, DeGroot J, Koeman RC, Sakkee N, Baeten DL, Gerlag DM, Tak PP. van Kuijk AW, et al. Among authors: baeten dl. PLoS One. 2010 Sep 3;5(9):e12556. doi: 10.1371/journal.pone.0012556. PLoS One. 2010. PMID: 20844595 Free PMC article. Clinical Trial.

2

Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP. Haringman JJ, et al. Ann Rheum Dis. 2005 Jun;64(6):834-8. doi: 10.1136/ard.2004.029751. Epub 2004 Dec 2. Ann Rheum Dis. 2005. PMID: 15576415 Free PMC article.

3

Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Smith MD, Baeten D, Ulfgren AK, McInnes IB, Fitzgerald O, Bresnihan B, Tak PP, Veale D; OMERACT synovial special interests group. Smith MD, et al. Ann Rheum Dis. 2006 Jan;65(1):93-100. doi: 10.1136/ard.2005.036905. Epub 2005 Jun 23. Ann Rheum Dis. 2006. PMID: 15975970 Free PMC article. Review.

4

Synovial tissue analysis in clinical trials.

Bresnihan B, Baeten D, Firestein GS, Fitzgerald OM, Gerlag DM, Haringman JJ, McInnes IB, Reece RJ, Smith MD, Ulfgren AK, Veale DJ, Tak PP; OMERACT 7 Special Interest Group. Bresnihan B, et al. J Rheumatol. 2005 Dec;32(12):2481-4. J Rheumatol. 2005. PMID: 16331792 Review.

5

Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.

Kruithof E, De Rycke L, Vandooren B, De Keyser F, FitzGerald O, McInnes I, Tak PP, Bresnihan B, Veys EM, Baeten D; OMERACT Special Interest Group on Synovial Analysis in Clinical Trials. Kruithof E, et al. Arthritis Rheum. 2006 Jun;54(6):1795-804. doi: 10.1002/art.21914. Arthritis Rheum. 2006. PMID: 16729282 Free article. Clinical Trial.

6

Pathogenesis of spondyloarthritis: insights from synovial membrane studies.

De Rycke L, Kruithof E, Vandooren B, Tak PP, Baeten D. De Rycke L, et al. Curr Rheumatol Rep. 2006 Aug;8(4):275-82. doi: 10.1007/s11926-006-0008-4. Curr Rheumatol Rep. 2006. PMID: 16839506 Review.

7

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis.

Haringman JJ, Gerlag DM, Smeets TJ, Baeten D, van den Bosch F, Bresnihan B, Breedveld FC, Dinant HJ, Legay F, Gram H, Loetscher P, Schmouder R, Woodworth T, Tak PP. Haringman JJ, et al. Arthritis Rheum. 2006 Aug;54(8):2387-92. doi: 10.1002/art.21975. Arthritis Rheum. 2006. PMID: 16869001 Free article. Clinical Trial.

8

Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!

Cantaert T, De Rycke L, Bongartz T, Matteson EL, Tak PP, Nicholas AP, Baeten D. Cantaert T, et al. Arthritis Rheum. 2006 Nov;54(11):3381-9. doi: 10.1002/art.22206. Arthritis Rheum. 2006. PMID: 17075816 Free article. Review. No abstract available.

9

A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis.

Cantaert T, Stone MA, ter Borg M, Mogg R, De Vries N, Wilson AG, Tak PP, Baeten D. Cantaert T, et al. Ann Rheum Dis. 2008 May;67(5):720-2. doi: 10.1136/ard.2007.082784. Epub 2007 Dec 11. Ann Rheum Dis. 2008. PMID: 18073264

10

Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints.

Polzer K, Baeten D, Soleiman A, Distler J, Gerlag DM, Tak PP, Schett G, Zwerina J. Polzer K, et al. Ann Rheum Dis. 2008 Nov;67(11):1610-6. doi: 10.1136/ard.2007.083394. Epub 2008 Jan 3. Ann Rheum Dis. 2008. PMID: 18174217

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page